Related Experiment Video
Updated: Dec 4, 2025

The Use of Gas Chromatography to Analyze Compositional Changes of Fatty Acids in Rat Liver Tissue during Pregnancy
Published on: March 13, 2014
Labetalol-Induced Hepatotoxicity during Pregnancy: A Case Report
Anna Whelan1, Joanna Izewski1, Charles Berkelhammer2
1Department of Obstetrics and Gynecology, University of Illinois College of Medicine at Chicago, Chicago, Illinois.
Abstract:
Background Drug-induced liver injury is a common cause of transaminitis, occurring in up to 5% of patients who are hospitalized for liver failure. In pregnancy, transaminitis is seen in conditions which may require expedited delivery. Case A 39-year-old G2P0010 at 27 2/7 weeks' gestation with chronic hypertension on labetalol was found to have elevated transaminases. Evaluation for preeclampsia, acute fatty liver, nonalcoholic steatohepatitis, cholelithiasis, infections, and autoimmune conditions were all negative. Labetalol was then discontinued, and liver biopsy was performed. After discontinuation of labetalol, her hepatitis improved, and she was discharged on hospital day 12 and went on to deliver at term. Conclusion Labetalol-induced hepatitis should be considered in the differential for transaminitis during pregnancy to prevent iatrogenic preterm delivery.
Related Concept Videos
Adrenergic Antagonists: ɑ and β-Receptor Blockers
Teratogenicity
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Mitral Valve Prolapse III: Nursing Management
Hormonal Regulation

